04/08/2011 - Prolor president Shai Novik told "Globes" that the trial's results exceeded expectations, and could enable the company to move directly to a Phase III clinical trial. The Phase III trial will include 150-200 adults with growth hormone deficiency and take six months to prove the treatment's efficacy and twelve months to confirm its safety. "We're working hard to submit the trial application in the first quarter of 2012," he said.
03/24/2010 - "Proceeds from the financing will enable us to reach Phase III trials of the human growth hormone. The money will be enough through mid-2012," said Novik. "During this period, we may already sign licensing agreements, which will generate more revenue."